valsartan has been researched along with natriuretic peptide, c-type in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Atar, D; Burnett, JC; Kompa, AR; Krum, H; Sangaralingham, SJ; von Lueder, TG; Wang, BH | 1 |
| Guo, J; Wong, PC; Zhang, A | 1 |
| Andersen, UØ; Goetze, JP; Gustafsson, F; Hansen, LH; Mark, PD; Plomgaard, P; Prickett, TCR; Terzic, D; Thonsgaard, S; Wewer Albrechtsen, NJ | 1 |
1 review(s) available for valsartan and natriuretic peptide, c-type
| Article | Year |
|---|---|
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure.
Topics: Alternative Splicing; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Designer Drugs; Drug Combinations; Drug Therapy, Combination; Endothelin-1; Heart Failure; Humans; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Natriuretic Peptides; Neprilysin; Peptidyl-Dipeptidase A; Protease Inhibitors; Receptors, Angiotensin; Renin-Angiotensin System; Snake Venoms; Tetrazoles; Valsartan | 2013 |
1 trial(s) available for valsartan and natriuretic peptide, c-type
| Article | Year |
|---|---|
Circulating Concentrations of C-Type Natriuretic Peptides Increase with Sacubitril/Valsartan Treatment in Healthy Young Men.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Neprilysin; Peptide Fragments; Sitagliptin Phosphate; Tetrazoles; Valsartan | 2022 |
1 other study(ies) available for valsartan and natriuretic peptide, c-type
| Article | Year |
|---|---|
The renal and cardiovascular effects of natriuretic peptides.
Topics: Aminobutyrates; Atrial Natriuretic Factor; Biphenyl Compounds; Disease Progression; Drug Combinations; Enalapril; Heart Failure; Humans; Kidney; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Natriuretic Peptides; Tetrazoles; Valsartan | 2017 |